Published Date: 17 Feb 2023
Many fears arise in childhood. And the science is very clear. Observational fear learning is especially common in children who model their fear without parental support.
Read Full NewsA phase 2 study at CTAD 2025 explores VHB937's potential in treating early Alzheimer disease, focusing on safety and efficacy in patients.
In an analysis of the phase 2a CLEAR MIND study presented at CTAD 2025, laromestrocel treatment was associated with reduced hippocampal neuroinflammation in patients with mild Alzheimer disease.
A new phase 3 clinical trial is underway to evaluate masupirdine, a selective 5-HT6 receptor antagonist, as a potential treatment for agitation in patients with Alzheimer’s disease.
Pulmonary Rehabilitation Reduces Type 2 Inflammation in High Inflammation Asthma
Mental Health Apps Gain High Uptake but Struggle With Adherence, Retention
6 Ophthalmology Headlines You Missed in October 2025
1.
Study Finds Actionable Mutations in Brain Mets of Breast Cancer Patients
2.
Study confirms link between breast density, higher breast cancer risk
3.
Large, Grade 4 Kidney Tumors Pose Risk of Early Cancer-Specific Mortality
4.
Alcohol Causes Cancer. We Should Be Drinking Less.
5.
Child Death Rates Are Rising in the U. s. ; Water Beads Warning; Cancer Studies Retracted.
1.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
2.
A New Hope: Exploring the Benefits of Exenteration for Cancer Patients
3.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
4.
Fibroma: Understanding the Causes, Symptoms, and Treatment Options
5.
The Power of White Blood Cells: How They Help Keep Us Healthy
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
2.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
4.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
5.
Navigating the Complexities of Ph Negative ALL - Part VIII
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation